Why CervoMed Inc.’s (CRVO) Stock Is Down 7.75%
As of Friday, July 10, CervoMed Inc.’s CRVO share price has dipped by 7.75%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | CRVO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $25.3 | $202.9 | 12% |
|
| Shares Out (Mil) | 15.1 | 55.4 | 26% |
|
| Institutional Ownership | 31.4% | 92.9% | 13% |
|
| Float (Mil) | 9.6 | 40.7 | 19% |
|
| Beta | -3.99 | 1.04 | 0% |
|
| Avg Daily Volume (000s) | 1,653 | 566 | 76% |
|
| Price Change (52-week) |
(77.0%) | 41.0% | 10% |
|
| Growth | CRVO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | na | (10.3%) | na |
|
| EPS (5yr) | na | 15.8% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.7%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | ($0.308) | ($1.763) | ($1.188) | |
| Month Ago EPS | ($0.450) | ($2.132) | ($1.385) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.447) | ($2.154) | ($1.503) | |
| Year/Year Chg | (21.0%) | (40.9%) | (71.2%) | |
| Financials | CRVO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $39 | na |
|
| Net Income (TTM) (Mil) | ($29) | ($44) | 21% |
|
| EPS (TTM) | ($2.596) | ($1.400) | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($27) | ($34) | 13% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | ($1) | 38% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $2 | $144 | 5% |
|
| Valuation | CRVO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.45 | 1.97 | 43% |
|
| P/E | na | 17.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | CRVO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.6% | na |
|
| Net Margin | na | (50.6%) | na |
|
| ROA | (109.8%) | (47.4%) | 5% |
|
| ROE | (131.5%) | (53.5%) | 7% |
|
| Liabilities to Assets | 18.6% | 29.7% | 12% |
|
| F-Score | 1 | 3 | 1% |
|
CervoMed Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors